RhumbLine Advisers’s Adaptive Biotechnologies ADPT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.54M Sell
182,872
-1,764
-1% -$28.1K ﹤0.01% 1737
2025
Q4
$3M Sell
184,636
-19,307
-9% -$315K ﹤0.01% 1660
2025
Q3
$3.05M Sell
203,943
-6,058
-3% -$73.8K ﹤0.01% 1676
2025
Q2
$2.45M Buy
210,001
+21,477
+11% +$195K ﹤0.01% 1779
2025
Q1
$1.4M Buy
188,524
+7,322
+4% +$56.3K ﹤0.01% 2005
2024
Q4
$1.09M Buy
181,202
+5,361
+3% +$29.6K ﹤0.01% 2214
2024
Q3
$900K Sell
175,841
-12,444
-7% -$54.2K ﹤0.01% 2317
2024
Q2
$682K Buy
188,285
+14,430
+8% +$45.8K ﹤0.01% 2452
2024
Q1
$558K Buy
173,855
+4,290
+3% +$16.6K ﹤0.01% 2604
2023
Q4
$831K Buy
169,565
+9,346
+6% +$42.6K ﹤0.01% 2366
2023
Q3
$873K Buy
160,219
+2,969
+2% +$19.6K ﹤0.01% 2286
2023
Q2
$1.06M Sell
157,250
-20,947
-12% -$156K ﹤0.01% 2255
2023
Q1
$1.57M Buy
178,197
+6,183
+4% +$54.5K ﹤0.01% 1930
2022
Q4
$1.31M Buy
172,014
+1,550
+0.9% +$12.1K ﹤0.01% 2005
2022
Q3
$1.21M Buy
170,464
+10,091
+6% +$95K ﹤0.01% 2036
2022
Q2
$1.3M Buy
160,373
+64,121
+67% +$564K ﹤0.01% 2008
2022
Q1
$1.34M Sell
96,252
-6,976
-7% -$110K ﹤0.01% 2007
2021
Q4
$2.9M Buy
103,228
+4,739
+5% +$145K ﹤0.01% 1694
2021
Q3
$3.35M Sell
98,489
-1,329
-1% -$48.1K ﹤0.01% 1596
2021
Q2
$4.08M Buy
99,818
+23,136
+30% +$899K 0.01% 1530
2021
Q1
$3.09M Sell
76,682
-9,246
-11% -$500K ﹤0.01% 1677
2020
Q4
$5.08M Buy
85,928
+1,928
+2% +$99.4K 0.01% 1348
2020
Q3
$4.08M Buy
84,000
+3,775
+5% +$159K 0.01% 1289
2020
Q2
$3.88M Buy
80,225
+20,179
+34% +$736K 0.01% 1354
2020
Q1
$1.67M Buy
60,046
+44,386
+283% +$1.24M ﹤0.01% 1639
2019
Q4
$469K Buy
15,660
+4,291
+38% +$123K ﹤0.01% 2389
2019
Q3
$351K Buy
+11,369
New +$464K ﹤0.01% 2493

Other funds holding ADPT